메뉴 건너뛰기




Volumn 8, Issue 11, 2010, Pages 1519-1521

Detecting, predicting and modifying cardiovascular risk: New and developing strategies

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 18; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MIPOMERSEN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROPROTEIN CONVERTASE SUBTILISIN; RESISTIN; RETINOL BINDING PROTEIN 4; SERINE PROTEINASE; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

EID: 78649384156     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.132     Document Type: Conference Paper
Times cited : (5)

References (5)
  • 1
    • 77953356167 scopus 로고    scopus 로고
    • Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) biomarker project
    • Blankenberg S, Zeller T, Saarela O et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) biomarker project. Circulation 121, 2388-2397 (2010).
    • (2010) Circulation , vol.121 , pp. 2388-2397
    • Blankenberg, S.1    Zeller, T.2    Saarela, O.3
  • 4
    • 77949485460 scopus 로고    scopus 로고
    • Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: A randomised, double-blind, placebo-controlled trial
    • Raal FJ, Santos RD, Blom DJ et al. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial. Lancet 375, 998-1006 (2010).
    • (2010) Lancet , vol.375 , pp. 998-1006
    • Raal, F.J.1    Santos, R.D.2    Blom, D.J.3
  • 5
    • 77956519356 scopus 로고    scopus 로고
    • A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo
    • Gupta N, Fisker N, Asselin MC et al. A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo. PLoS ONE 5, e10682 (2010).
    • (2010) PLoS ONE , vol.5
    • Gupta, N.1    Fisker, N.2    Asselin, M.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.